- Home
- XERS vs NQP Comparison
XERS vs NQP Comparison
Compare XERS & NQP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XERS
- NQP
- Stock Information
- Founded
- XERS 2005
- NQP 1990
- Country
- XERS United States
- NQP United States
- Employees
- XERS N/A
- NQP N/A
- Industry
- XERS Biotechnology: Pharmaceutical Preparations
- NQP Trusts Except Educational Religious and Charitable
- Sector
- XERS Health Care
- NQP Finance
- Exchange
- XERS Nasdaq
- NQP Nasdaq
- Market Cap
- XERS 628.7M
- NQP 410.1M
- IPO Year
- XERS 2018
- NQP N/A
- Fundamental
- Price
- XERS $5.16
- NQP $11.35
- Analyst Decision
- XERS Strong Buy
- NQP
- Analyst Count
- XERS 5
- NQP 0
- Target Price
- XERS $6.10
- NQP N/A
- AVG Volume (30 Days)
- XERS 2.3M
- NQP 58.4K
- Earning Date
- XERS 05-08-2025
- NQP 01-01-0001
- Dividend Yield
- XERS N/A
- NQP 3.21%
- EPS Growth
- XERS N/A
- NQP N/A
- EPS
- XERS N/A
- NQP N/A
- Revenue
- XERS $222,551,000.00
- NQP N/A
- Revenue This Year
- XERS $31.75
- NQP N/A
- Revenue Next Year
- XERS $21.09
- NQP N/A
- P/E Ratio
- XERS N/A
- NQP N/A
- Revenue Growth
- XERS 29.88
- NQP N/A
- 52 Week Low
- XERS $1.72
- NQP $9.65
- 52 Week High
- XERS $6.07
- NQP $11.89
- Technical
- Relative Strength Index (RSI)
- XERS 63.30
- NQP 56.60
- Support Level
- XERS $4.26
- NQP $11.23
- Resistance Level
- XERS $4.77
- NQP $11.44
- Average True Range (ATR)
- XERS 0.28
- NQP 0.10
- MACD
- XERS 0.08
- NQP 0.03
- Stochastic Oscillator
- XERS 91.32
- NQP 80.85
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).
About NQP Nuveen Pennsylvania Quality Municipal Income Fund
Nuveen Pennsylvania Quality Municipal Income Fund is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal and Pennsylvania income taxes and to enhance portfolio value relative to the municipal bond market by investing in municipal securities that are exempt from federal, Pennsylvania state and local income taxes. It invests a majority of its assets in securities that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.